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ABSTRACT 
Selective retina therapy (SRT) is a short pulse (µs-regime) alternative to conventional laser photocoagulation (LPC) for 
treatment of retinal diseases. LPC leads to collateral damage of retinal layers adjacent to the retinal pigment epithelium 
(RPE), including healthy, non-regenerative photoreceptors due to the high thermal load, whereas in SRT, RPE cells are 
destroyed by microbubbles without damaging the neuronal retina. A novel experimental SRT laser operating at 532 nm 
wavelength can deliver 2 – 20 μs pulse sequences. Its tight integration into an upgraded diagnostic SPECTRALIS system 
combines beam control for treatment planning with real-time optical coherence tomography (OCT) overexposure 
protection of the photoreceptors. This “Spectralis Centaurus” system, was built and preliminary tested on porcine ex-vivo 
samples, reaching an unprecedented accuracy with unique planning and follow-up capabilities for upcoming clinical 
cellular level micro-surgery. The combination of OCT with SRT selectively limits cell death to the RPE by precisely 
controlling energy deposition while optically monitoring tissue response. 
Keywords: Selective retina therapy, Retinal pigment epithelium, (170.0170) Medical optics and biotechnology, 
(170.4500) Optical coherence tomography, (170.4460) Ophthalmic optics and devices, (170.3890) Medical optics 
instrumentation, (170.4470) Ophthalmology 
 
1. INTRODUCTION 
Whereas diabetic retinopathy with diabetic macular edema is the leading causes of blindness in the working-age 
population, age-related macular degeneration remains the major cause of severe vision loss of the elderly in industrialized 
countries1,2,3,4. Central serous chorioretinopathy is mostly transient but can cause permanent visual compromise in some 
patients. To treat these retinal diseases, which are associated with retinal pigment epithelium (RPE) dysfunction, 
conventional laser photocoagulation (LPC) techniques were shown to be effective5,6. Today, LPC still remains a widely 
used method, but due to the slow heating process and the strong heat dissipation into the surroundings, the use of long 
laser pulses in the millisecond-range or even continuous wave lasers application lead to collateral damage of surrounding 
components like Bruch’s membrane, choriocapillaris and particularly, healthy overlying photoreceptor cells7,8, which in 
turn leads to scotoma, reduced night vision, and disruption of the retinal anatomy from scarring9,10. These adverse effects 
have led to the development of new forms of laser treatments, whereas selective retina therapy (SRT) is particularly suitable 
since it selectively targets RPE cells without affecting the neighboring neural retina, choroid, and photoreceptors. The 
basis for this selective RPE damage are the strongly light-absorbing melanosomes inside RPE cells, where about 50% of 
the incident light in the green spectral range11 is converted to heat. Due to the thermal confinement in SRT, ~1 microsecond 
long laser pulses cause heating of melanosomes to at least 150°C, which leads to vaporization of surrounding liquid and 
subsequent microbubble formation on the melanosome surface12. The consequence of this rapid expansion is partial or 
complete RPE cell disruption followed by RPE cell death, without severely affecting adjacent retinal layers13. This 
selective cell death is desired, since resulting lesions are substituted later on by expansion and proliferation of highly 
regenerative RPE cells8. This stimulation of RPE cell migration, local inflammation and replacement of old cells finally 
leads to improved metabolism at target sites without scarring14. The key challenge of photoreceptor-cell conserving therapy 
of the retina is the complexity of radiant exposure control due to inter- and intra-patient variability of tissue absorption. 
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Since SRT suffers from the lack of real-time optical feedback and being undetectable during visual inspection of the 
fundus, the selective RPE damage caused by this therapy is practically and efficiently only retrospectively identified via 
fundus fluorescein angiography (FFA). However, FFA has two major drawbacks. It is medically invasive and second, it 
cannot be used as a real-time dosimetry tool. Besides other novel detection methods, like opto-acoustics, light reflection 
and small bandwith-interferometry, optical coherence tomography (OCT) can provide reliable dosimetry control for SRT. 
With its optical access, OCT can image the three-dimensional structure and comfortably discriminate the level of RPE 
lesions13 indirectly as a change of signal strength15. This method was described by Steiner et al.16,17,18,19; effects of treatment 
laser pulses were indirectly detected as a change of intensity in axial OCT scans (A-scans), which correspond to the local 
reflectivity of tissue. Using signal changes of OCT M-scans, Kaufmann et al.15,20 were able to precisely predict real-time 
retinal lesions during SRT. Furthermore, Kaufmann et al. showed, that SRT in ramp-mode combined with a fast algorithm-
based OCT treatment stop allows reliable dosimetry during SRT. The system presented here implements these findings 
within a multimodal commercial-class platform with targeting clinical application and features a novel experimental SRT 
laser. 
2. MATERIALS AND METHODS 
The Spectralis Centaurus system (Figure 1, 2) was engineered and built by the HuCE optoLab (optical laboratory of the 
institute for human centered engineering) in cooperation with academic and industrial partners. The Spectralis Centaurus 
consists of an opto-mechanically upgraded diagnostic imaging platform (SPECTRALIS HRA+OCT, Heidelberg 
Engineering, Heidelberg, DE) together with an experimental SRT laser (MERILAS, Meridian, Thun, CH). The system 
utilizes OCT M-scans (motion-mode) for dosimetry control during treatment and takes advantage of all technologies that 
the SPECTRALIS platform already offers. Therefore, the device can be used for diagnosis of retinal diseases, intervention 
planning, SRT treatment, and follow-up examinations. The in house developed Centaurus treatment software (C++) is 
used for treatment planning on the fundus and implements the laser control. 
 
Figure 1. (A) Spectralis Centaurus system: upgraded diagnostic imaging platform (SPECTRALIS HRA+OCT, Heidelberg 
Engineering, Heidelberg, DE) together with the experimental SRT laser (MERILAS, Meridian, Thun, CH) (B) and placement 
of an ex-vivo porcine eye in front of the system (C) 
The experimental SRT laser operates with pulses of 2 – 20 μs durations, emits at 532 nm, has a peak radiant power of 30 
W and it delivers a variable repetition rate of 100 to 500 Hz. The optimized imaging system achieves a retinal top hat 
square of 120x120µm².  
The OCT part of the Spectralis Centaurus is a spectral-domain, also called Fourier-domain, OCT system that allows high-
speed and high-resolution imaging of the retina. The infrared beam of the super-luminescence diode of the OCT laser has 
an average wavelength of 870 nm with a bandwidth of 73 nm (840 nm – 913 nm). In the experiment presented here, OCT 
is used to observe signal variations in time-resolved sequences of A-scans, so called M-scans, which are correlated to the 
creation of RPE lesions. In total, 256 A-scans are recorder and stitched together to one M-scan, which leads to time resolved 
records of 7.76 ms duration by an A-scan rate of 33 kHz. The SRT laser was triggered to take place within this M-scan 
time slot. The recorded signal changes, so called fringe washouts, then allow to predict physiological lesions in the RPE. 
Several ex-vivo porcine eye experiments were carried out to test the full parameter set of the experimental SRT laser and 
to investigate its selectivity. Experiments took place in mornings well within the common cellular survivability window 
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of five hours, within three hours post-mortem after extraction, from a local slaughter-house. During collection the porcine 
eyes were stored in normal saline. (9g NaCl/l). Before treatment, all superfluous muscles were surgically removed from 
the sclera. 
As shown in Figure 5, for the experiment a treatment pattern with 19 laser photocoagulation (LPC) marker lesions was 
used. The marker lesions were applied by using the experimental SRT laser in CW-mode (200 ms pulse duration and 200 
mW pulse power). The marker lesions served as orientation guide in the evaluation process after the treatment. Within the 
marker lesions, the SRT treatment pattern, with a dimension of 10 x 10 lesions, was located. The pulse duration was 
increased from top bottom (2 μs to 20), and the radiant energy was increases from left (20 μJ) to right (maximal 340 μJ at 
20 μs). During the treatment, M-scans were recorded with the Spectralis Centaurus system. 
 
Figure 2. Setup and functionality of the Spectralis Centaurus system: The SRT and OCT laser beams are combined by a 
dichroic mirror (black-dashed rectangle). Retina scanning is performed by a galvo-scanner, a chromatically corrected objective 
focuses the collinear SRT and OCT laser beams. Reflected light is separately guided towards a spectrometer and a fast diode. 
After SRT treatment, the porcine eyes were prepared for the staining and subsequent evaluation by fluorescence 
microscopy. The utilized two-color assay Live-Dead staining kit (L3224, Thermo Fisher Scientific, Waltham, MA, US) 
was used to determine vitality of RPE cells after SRT. Green-fluorescent calcein-AM (live) and red-fluorescent ethidium 
homodimer-1 (EthD-1, dead) indicate function or loss of plasma membrane integrity. The eyes were cut in half posterior 
to the lens, the vitreous body of the porcine eye was removed, and the treatment pattern had to be located by searching the 
LPC marker lesions. The LPC marker lesions appear as grayish spots on the retina and were always allocated in a 
rectangular grid. After localization, an area of approximately 10 x 10 mm, centered on the treatment pattern was cut free, 
stained and further washed in PBS. Evaluation took place under a fluorescence microscope (Axio Lab.A1, Carl Zeiss, 
Oberkochen, DE) and were documented by a camera (Gryphax Progres, Jenoptik, Jena, DE). Post-processing was 
performed with Fiji21. 
3. RESULTS 
The experimental SRT laser’s full range of available parameters was tested to verify SRT and OCT-controlled SRT 
feasibility. The ability to apply SRT lesions could be demonstrated for all pulse durations, ranging from 2 to 20 μs by 
applying single pulses. In Figure 3, the pulse duration is increased from top (2 μs) to bottom (20 μs), the radiant energy 
increases from left (20 μJ) to right (maximal 340 μJ at 20 μs). However, no SRT lesions were observed for pulses with 20 
μJ radiant energy. 
As depicted in Figure 3-B, averaged OCT B-scans can serve as a first tool to investigate the experimental SRT laser’s 
selectivity. In total eight porcine eyes were treated. However, only five were evaluated with Live-Dead staining to get a 
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deeper insight into the relation between laser parameters and their impact on tissue. The full live-dead evaluation of a 
porcine RPE section is presented in Figure 5. 
 
Figure 3. (A) IR fundus image of a porcine eye after SRT showing LPC marker lesions (e.g. black triangles) and SRT lesions 
in the SRT region (black-dashed rectangle) were the treatment pattern was applied. By analyzing line 9 (green arrow) of the 
treatment pattern in the IR fundus image (A), no retinal damage threshold can be documented in the corresponding OCT B-
scan (B) by observing the SRT region (white-dashed rectangle) between the two LPC marker lesions (white triangles). By 
looking at the corresponding RPE layer (C) evaluated with live-dead staining, RPE lesions are highly present in the SRT 
region (white-dashed rectangle) between the two LPC marker lesions (white triangles). The presented section was treated with 
increasing pulse radiant energy from left to right (20 to 330 μJ) with a pulse duration of 18 μs. 
As depicted in Figure 4, the Spectralis Centaurus system was able to observe signal variations in time-resolved sequences 
of A-scans (M-scans) which are correlated to the creation of RPE lesions. These findings were made for all pulse durations 
from 2 μs to 20 μs. 
 
Figure 4. Selection of signal washouts for different pulse durations and radiant energies recorded with the Spectralis Centaurus 
system. It can be observed that the change of OCT signal strength can be different depending on pulse duration and radiant 
energy. 
4. DISCUSSION 
The experimental SRT laser was tested together with the Spectralis Centaurus system in multiple porcine sessions with the 
full extent of its parameters. The result of the experiments with different laser pulse durations correspond to the findings 
of similar studies. The results presented in Figure 3 suggest that the experimental SRT laser is selective for pulse durations 
up to 20 μs because no change in the tissue’s structure due to strong heat dissipation can be observed compared to the LPC 
marker lesions. However, the pulse duration where thermal damage will take place is not clear defined jet. In general, laser 
irradiation should be delivered with a pulse duration shorter than the time needed for heat to diffuse toward surrounding 
tissue (thermal relaxation time).  
The non-linear increase in lesion diameter with increasing energy observed in Figure 5 is thought to be the consequence 
of scattering in the upper retina layer and a slight defocusing on the curved retina.  
With the current system a more detailed research is possible and implementing histology might be useful to investigate the 
boundary between microbubble effect and thermal coagulation effects. In-vivo experiments must show if irradiation with 
SRT pulse durations up to 20 μs induces anatomical changes or if such treatment is selective. 
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Figure 5. Depicted is the full extent of a live-dead evaluation of porcine RPE after SRT irradiation. The radiant energy was 
increased from left to right (20 to maximal 340 μJ by steps and the pulse duration from top to bottom (2 to 20 μs). It can be 
observed that marker lesions can occur as completely destroyed RPE (i) or with attached retinal tissue (ii) due to some kind 
of welding process, which is typically provoked by heat dissipation in LPC. The evaluation shows that the experimental SRT 
laser is able to create SRT lesions (iv) with its whole parameter set. 
5. CONCLUSION AND OUTLOOK
For investigation of the clinical potential of OCT-controlled SRT, a system combining an opto-mechanically upgraded 
diagnostic imaging platform with an experimental green SRT laser was built. This Spectralis Centaurus system will allow 
accurate SRT treatment planning and energy dosing by leveraging high speed automated M-scan signal washout detection 
during ramping up the pulse energy. Being a multimodal system the Spectralis Centaurus system is not a sole treatment 
device but offers integrated diagnostic modalities that the preceding diagnostic imaging platform offered. This makes it a 
well-proven and reliable device for diagnosis, intervention planning, treatment and follow-up examination. It has the 
potential to promote SRT as the standard therapy for patients suffering from RPE-related retinal diseases. Nevertheless, 
further studies are ongoing to improve the safety of SRT with pulse durations up to 20 μs by confirming the exact 
therapeutic window and safety range. 
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